Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ACTEMRA DIN 02350092

Status: Marketed
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: TOCILIZUMAB
Available to quote

Health Canada record

Active ingredient(s)TOCILIZUMAB 80 MG
Dosage formSolution
RouteIntravenous
ScheduleSCHEDULE D; PRESCRIPTION
ClassHuman
ATCL04AC07 TOCILIZUMAB
Original market date26-May-2010
Current status date26-May-2010
SourceHealth Canada DPD

Establishment licence of the holder

Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TOCILIZUMAB

DINProductCompanyFormStrengthStatus
02350106ACTEMRAHOFFMANN-LA ROCHE LIMITEDSolutionTOCILIZUMAB 200 MGMarketed
02350114ACTEMRAHOFFMANN-LA ROCHE LIMITEDSolutionTOCILIZUMAB 400 MGMarketed
02424770ACTEMRAHOFFMANN-LA ROCHE LIMITEDSolutionTOCILIZUMAB 162 MGMarketed
02483327ACTEMRAHOFFMANN-LA ROCHE LIMITEDSolutionTOCILIZUMAB 162 MGMarketed
02562049AVTOZMACELLTRION INC.SolutionTOCILIZUMAB 400 MGMarketed
02562022AVTOZMACELLTRION INC.SolutionTOCILIZUMAB 80 MGMarketed
02562030AVTOZMACELLTRION INC.SolutionTOCILIZUMAB 200 MGMarketed
02562057AVTOZMACELLTRION INC.SolutionTOCILIZUMAB 162 MGMarketed
02562065AVTOZMACELLTRION INC.SolutionTOCILIZUMAB 162 MGMarketed
02552450TYENNEFRESENIUS KABI CANADA LTDSolutionTOCILIZUMAB 80 MGMarketed
02552469TYENNEFRESENIUS KABI CANADA LTDSolutionTOCILIZUMAB 200 MGMarketed
02552477TYENNEFRESENIUS KABI CANADA LTDSolutionTOCILIZUMAB 400 MGMarketed
02552485TYENNEFRESENIUS KABI CANADA LTDSolutionTOCILIZUMAB 162 MGMarketed
02552493TYENNEFRESENIUS KABI CANADA LTDSolutionTOCILIZUMAB 162 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
113482010-04-30New Drug Submission (NDS)
Request a quote for ACTEMRA

How to read a Canadian DIN record